Luteolin Protects Pancreatic β Cells against Apoptosis through Regulation of Autophagy and ROS Clearance

Diabetes, which is mainly characterized by increased apoptosis and dysfunction of beta (β) cells, is a metabolic disease caused by impairment of pancreatic islet function. Previous studies have demonstrated that death-associated protein kinase-related apoptosis-inducing kinase-2 (Drak2) is involved in regulating β cell survival. Since natural products have multiple targets and often are multifunctional, making them promising compounds for the treatment of diabetes, we identified Drak2 inhibitors from a natural product library. Among the identified products, luteolin, a flavonoid, was found to be the most effective compound. In vitro, luteolin effectively alleviated palmitate (PA)-induced apoptosis of β cells and PA-induced impairment of primary islet function. In vivo, luteolin showed a tendency to lower blood glucose levels. It also alleviated STZ-induced apoptosis of β cells and metabolic disruption in mice. This function of luteolin partially relied on Drak2 inhibition. Furthermore, luteolin was also found to effectively relieve oxidative stress and promote autophagy in β cells, possibly improving β cell function and slowing the progression of diabetes. In conclusion, our findings show the promising effect of Drak2 inhibitors in relieving diabetes and offer a potential therapeutic target for the protection of β cells. We also reveal some of the underlying mechanisms of luteolin’s cytoprotective function.

[1]  C. Xiao,et al.  The protection of luteolin against diabetic cardiomyopathy in rats is related to reversing JNK-suppressed autophagy. , 2023, Food & function.

[2]  Xinchao Li,et al.  New insights into the characteristics of DRAK2 and its role in apoptosis: From molecular mechanisms to clinically applied potential , 2022, Frontiers in Pharmacology.

[3]  C. Gonçalves-de-Albuquerque,et al.  Flavonols and Flavones as Potential anti-Inflammatory, Antioxidant, and Antibacterial Compounds , 2022, Oxidative medicine and cellular longevity.

[4]  P. Plastina,et al.  Aluminum(III), iron(III) and copper(II) complexes of luteolin: stability, antioxidant, and anti-inflammatory properties , 2021, Journal of Molecular Liquids.

[5]  Yimin Yan,et al.  Luteolin alleviates cognitive impairment in Alzheimer’s disease mouse model via inhibiting endoplasmic reticulum stress-dependent neuroinflammation , 2021, Acta Pharmacologica Sinica.

[6]  E. Walker,et al.  A Selective Look at Autophagy in Pancreatic β-Cells , 2021, Diabetes.

[7]  P. Conti,et al.  Powerful anti‐inflammatory action of luteolin: Potential increase with IL‐38 , 2021, BioFactors.

[8]  Jingcheng Dong,et al.  Luteolin inhibits autophagy in allergic asthma by activating PI3K/Akt/mTOR signaling and inhibiting Beclin-1-PI3KC3 complex. , 2021, International immunopharmacology.

[9]  M. Ashrafizadeh,et al.  Autophagy regulation using luteolin: new insight into its anti-tumor activity , 2020, Cancer Cell International.

[10]  M. Rezaie,et al.  Structure-Antioxidant Activity Relationships of Luteolin and Catechin. , 2020, Journal of food science.

[11]  G. Liang,et al.  Luteolin protects against diabetic cardiomyopathy by inhibiting NF-κB-mediated inflammation and activating the Nrf2-mediated antioxidant responses. , 2019, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  F. Nan,et al.  Sulfuretin protects hepatic cells through regulation of ROS levels and autophagic flux , 2018, Acta Pharmacologica Sinica.

[13]  Dhiraj Kumar,et al.  Can luteolin be a therapeutic molecule for both colon cancer and diabetes? , 2018, Briefings in functional genomics.

[14]  S. Inzucchi,et al.  Metformin: clinical use in type 2 diabetes , 2017, Diabetologia.

[15]  B. Han,et al.  Discovery of benzofuran-3(2H)-one derivatives as novel DRAK2 inhibitors that protect islet β-cells from apoptosis. , 2017, European journal of medicinal chemistry.

[16]  Xiaodong Zheng,et al.  Mulberry anthocyanin extract ameliorates insulin resistance by regulating PI3K/AKT pathway in HepG2 cells and db/db mice. , 2016, The Journal of nutritional biochemistry.

[17]  S. Ray,et al.  Anti-tumor activities of luteolin and silibinin in glioblastoma cells: overexpression of miR-7-1-3p augmented luteolin and silibinin to inhibit autophagy and induce apoptosis in glioblastoma in vivo , 2016, Apoptosis.

[18]  I. Sumara,et al.  Insulin secretory granules control autophagy in pancreatic β cells , 2015, Science.

[19]  N. Sarvetnick,et al.  Inhibition of Autophagic Turnover in β-Cells by Fatty Acids and Glucose Leads to Apoptotic Cell Death* , 2014, The Journal of Biological Chemistry.

[20]  Myung-Shik Lee Role of islet β cell autophagy in the pathogenesis of diabetes , 2014, Trends in Endocrinology & Metabolism.

[21]  A. Kimchi,et al.  DAPK2 is a novel regulator of mTORC1 activity and autophagy , 2014, Cell Death and Differentiation.

[22]  P. Herdewijn,et al.  Discovery of dual death-associated protein related apoptosis inducing protein kinase 1 and 2 inhibitors by a scaffold hopping approach. , 2014, Journal of medicinal chemistry.

[23]  A. Kimchi,et al.  The DAP-kinase interactome , 2014, Apoptosis.

[24]  A. Kimchi,et al.  DAP-kinase and autophagy , 2014, Apoptosis.

[25]  S. Yagihashi,et al.  Exendin-4 improves β-cell function in autophagy-deficient β-cells. , 2013, Endocrinology.

[26]  Xiaoqun Duan,et al.  Anti-diabetic effects of puerarin, isolated from Pueraria lobata (Willd.), on streptozotocin-diabetogenic mice through promoting insulin expression and ameliorating metabolic function. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[27]  S. Oh,et al.  Autophagy deficiency in beta cells leads to compromised unfolded protein response and progression from obesity to diabetes in mice , 2012, Diabetologia.

[28]  A. Kimchi,et al.  PKD is a kinase of Vps34 that mediates ROS-induced autophagy downstream of DAPk , 2011, Cell Death and Differentiation.

[29]  O. Shirihai,et al.  Fatty Acids Suppress Autophagic Turnover in β-Cells* , 2011, The Journal of Biological Chemistry.

[30]  W. Han,et al.  Deficiency in RNA editing enzyme ADAR2 impairs regulated exocytosis , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[31]  M. Düfer,et al.  Oxidative stress and beta-cell dysfunction , 2010, Pflügers Archiv - European Journal of Physiology.

[32]  M. Eisenstein,et al.  Phosphorylation of Beclin 1 by DAP-kinase promotes autophagy by weakening its interactions with Bcl-2 and Bcl-XL , 2009, Autophagy.

[33]  B. Han,et al.  Drak2 Is Upstream of p70S6 Kinase: Its Implication in Cytokine-Induced Islet Apoptosis, Diabetes, and Islet Transplantation1 , 2009, The Journal of Immunology.

[34]  Miriam Eisenstein,et al.  DAP‐kinase‐mediated phosphorylation on the BH3 domain of beclin 1 promotes dissociation of beclin 1 from Bcl‐XL and induction of autophagy , 2009, EMBO reports.

[35]  Hongyu Luo,et al.  Drak2 overexpression results in increased β‐cell apoptosis after free fatty acid stimulation , 2008, Journal of cellular biochemistry.

[36]  Kun Wook Chung,et al.  Loss of autophagy diminishes pancreatic beta cell mass and function with resultant hyperglycemia. , 2008, Cell metabolism.

[37]  Masaaki Komatsu,et al.  Autophagy is important in islet homeostasis and compensatory increase of beta cell mass in response to high-fat diet. , 2008, Cell metabolism.

[38]  R. Robertson,et al.  Diabetes, glucose toxicity, and oxidative stress: A case of double jeopardy for the pancreatic islet beta cell. , 2006, Free radical biology & medicine.

[39]  R. Robertson,et al.  β-Cell Glucose Toxicity, Lipotoxicity, and Chronic Oxidative Stress in Type 2 Diabetes , 2004 .

[40]  J. Richardson,et al.  Essential Role of STAT3 in Body Weight and Glucose Homeostasis , 2004, Molecular and Cellular Biology.

[41]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[42]  A. Kimchi,et al.  Death-Associated Protein Kinase-Related Protein 1, a Novel Serine/Threonine Kinase Involved in Apoptosis , 2000, Molecular and Cellular Biology.

[43]  S. Akira,et al.  Death-associated protein kinase 2 is a new calcium/calmodulin-dependent protein kinase that signals apoptosis through its catalytic activity , 1999, Oncogene.

[44]  S. Akira,et al.  DRAKs, Novel Serine/Threonine Kinases Related to Death-associated Protein Kinase That Trigger Apoptosis* , 1998, The Journal of Biological Chemistry.

[45]  Shizuo Akira,et al.  ZIP Kinase, a Novel Serine/Threonine Kinase Which Mediates Apoptosis , 1998, Molecular and Cellular Biology.

[46]  J. Levy,et al.  U.K. Prospective Diabetes Study 16: Overview of 6 Years' Therapy of Type II Diabetes: A Progressive Disease , 1995, Diabetes.

[47]  Yong Li,et al.  Quercetin and quercitrin protect against cytokine‑induced injuries in RINm5F β-cells via the mitochondrial pathway and NF-κB signaling. , 2013, International journal of molecular medicine.

[48]  R. Robertson,et al.  Beta-cell glucose toxicity, lipotoxicity, and chronic oxidative stress in type 2 diabetes. , 2004, Diabetes.

[49]  Robert A Rizza,et al.  Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. , 2003, Diabetes.

[50]  A. Kimchi,et al.  Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death. , 1995, Genes & development.